Drug-Induced Liver Injury Induced by Bioflavonoids

Drug-induced liver injury (DILI) is a relatively rare disease with a vast spectre of clinical manifestations. Its diagnosis is based on the exclusion of other causes of liver disease. The identification of a causal agent is based on the temporal relation between the symptoms and their resolution aft...

Descripción completa

Detalles Bibliográficos
Autores principales: Pais, João P, Mota, Rita, Cruz, Mariana, Cambão, Ana R, Nascimento, Ana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8760611/
https://www.ncbi.nlm.nih.gov/pubmed/35070523
http://dx.doi.org/10.7759/cureus.20453
_version_ 1784633360088301568
author Pais, João P
Mota, Rita
Cruz, Mariana
Cambão, Ana R
Nascimento, Ana
author_facet Pais, João P
Mota, Rita
Cruz, Mariana
Cambão, Ana R
Nascimento, Ana
author_sort Pais, João P
collection PubMed
description Drug-induced liver injury (DILI) is a relatively rare disease with a vast spectre of clinical manifestations. Its diagnosis is based on the exclusion of other causes of liver disease. The identification of a causal agent is based on the temporal relation between the symptoms and their resolution after stopping the suspected drug. Many drugs have been described as causative agents of DILI; however, bioflavonoids have never been implied with an idiosyncratic DILI in the literature.
format Online
Article
Text
id pubmed-8760611
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-87606112022-01-20 Drug-Induced Liver Injury Induced by Bioflavonoids Pais, João P Mota, Rita Cruz, Mariana Cambão, Ana R Nascimento, Ana Cureus Internal Medicine Drug-induced liver injury (DILI) is a relatively rare disease with a vast spectre of clinical manifestations. Its diagnosis is based on the exclusion of other causes of liver disease. The identification of a causal agent is based on the temporal relation between the symptoms and their resolution after stopping the suspected drug. Many drugs have been described as causative agents of DILI; however, bioflavonoids have never been implied with an idiosyncratic DILI in the literature. Cureus 2021-12-16 /pmc/articles/PMC8760611/ /pubmed/35070523 http://dx.doi.org/10.7759/cureus.20453 Text en Copyright © 2021, Pais et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Internal Medicine
Pais, João P
Mota, Rita
Cruz, Mariana
Cambão, Ana R
Nascimento, Ana
Drug-Induced Liver Injury Induced by Bioflavonoids
title Drug-Induced Liver Injury Induced by Bioflavonoids
title_full Drug-Induced Liver Injury Induced by Bioflavonoids
title_fullStr Drug-Induced Liver Injury Induced by Bioflavonoids
title_full_unstemmed Drug-Induced Liver Injury Induced by Bioflavonoids
title_short Drug-Induced Liver Injury Induced by Bioflavonoids
title_sort drug-induced liver injury induced by bioflavonoids
topic Internal Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8760611/
https://www.ncbi.nlm.nih.gov/pubmed/35070523
http://dx.doi.org/10.7759/cureus.20453
work_keys_str_mv AT paisjoaop druginducedliverinjuryinducedbybioflavonoids
AT motarita druginducedliverinjuryinducedbybioflavonoids
AT cruzmariana druginducedliverinjuryinducedbybioflavonoids
AT cambaoanar druginducedliverinjuryinducedbybioflavonoids
AT nascimentoana druginducedliverinjuryinducedbybioflavonoids

Ejemplares similares